1. Complete response induced by half dose of sorafenib administration in advanced hepatocellular carcinoma with peritoneal dissemination
   Naoki Morimoto et al, 2014, Kanzo CrossRef
2. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1–RAGE and AKT pathways
   Ping Cheng et al, 2014, Biochemical and Biophysical Research Communications CrossRef
3. Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
   Matthias Pinter et al, 2018, memo - Magazine of European Medical Oncology CrossRef
4. Long-term sustained complete response with off-therapy to sorafenib in advanced hepatocellular carcinoma: a case report
   Takeshi Koujima et al, 2020, Kanzo CrossRef
5. Feasibility of global miRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenib
   Jan Peveling-Oberhag et al, 2015, Clinical Science CrossRef
6. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature
   Catherine Atkin et al, 2017, BMC Gastroenterology CrossRef